These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 28550595)

  • 41. Colistin: re-emergence of the 'forgotten' antimicrobial agent.
    Dhariwal AK; Tullu MS
    J Postgrad Med; 2013; 59(3):208-15. PubMed ID: 24029199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MCR: modern colistin resistance.
    Caniaux I; van Belkum A; Zambardi G; Poirel L; Gros MF
    Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):415-420. PubMed ID: 27873028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Colistin: new lessons on an old antibiotic.
    Yahav D; Farbman L; Leibovici L; Paul M
    Clin Microbiol Infect; 2012 Jan; 18(1):18-29. PubMed ID: 22168320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modified Colistin Regimen for Critically Ill Patients with Acute Renal Impairment and Continuous Renal Replacement Therapy.
    Menna P; Salvatorelli E; Mattei A; Cappiello D; Minotti G; Carassiti M
    Chemotherapy; 2018; 63(1):35-38. PubMed ID: 29334366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
    Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
    Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Whole-Body Physiologically Based Pharmacokinetic Model for Colistin and Colistin Methanesulfonate in Rat.
    Bouchene S; Marchand S; Couet W; Friberg LE; Gobin P; Lamarche I; Grégoire N; Björkman S; Karlsson MO
    Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):407-422. PubMed ID: 29665289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of colistin methanesulfonate and formed colistin in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis.
    Koomanachai P; Landersdorfer CB; Chen G; Lee HJ; Jitmuang A; Wasuwattakul S; Sritippayawan S; Li J; Nation RL; Thamlikitkul V
    Antimicrob Agents Chemother; 2014; 58(1):440-6. PubMed ID: 24189256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous colistimethate for multidrug-resistant Gram-negative bacteria.
    Zavascki AP; Li J
    Lancet Infect Dis; 2008 Jul; 8(7):403-5. PubMed ID: 18582831
    [No Abstract]   [Full Text] [Related]  

  • 50. Emergence of colistin-resistant bacteria in humans without colistin usage: a new worry and cause for vigilance.
    Olaitan AO; Morand S; Rolain JM
    Int J Antimicrob Agents; 2016 Jan; 47(1):1-3. PubMed ID: 26712133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Results of a multicenter study investigating plasmid mediated colistin resistance genes (mcr-1 and mcr-2) in clinical Enterobacteriaceae ısolates from Turkey].
    Sarı AN; Süzük S; Karatuna O; Öğünç D; Karakoç AE; Çizmeci Z; Alışkan HE; Cömert F; Bakıcı MZ; Akpolat N; Çilli FF; Zer Y; Karataş A; Akgün Karapınar B; Bayramoğlu G; Özdamar M; Kalem F; Delialioğlu N; Aktaş E; Yılmaz N; Gürcan Ş; Gülay Z
    Mikrobiyol Bul; 2017 Jul; 51(3):299-303. PubMed ID: 28929967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.
    Garonzik SM; Li J; Thamlikitkul V; Paterson DL; Shoham S; Jacob J; Silveira FP; Forrest A; Nation RL
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3284-94. PubMed ID: 21555763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosing.
    Jitmuang A; Nation RL; Koomanachai P; Chen G; Lee HJ; Wasuwattakul S; Sritippayawan S; Li J; Thamlikitkul V; Landersdorfer CB
    J Antimicrob Chemother; 2015; 70(6):1804-11. PubMed ID: 25698772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between colistin dose and microbiologic outcomes in patients with multidrug-resistant gram-negative bacteremia.
    Vicari G; Bauer SR; Neuner EA; Lam SW
    Clin Infect Dis; 2013 Feb; 56(3):398-404. PubMed ID: 23090926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resurgence of colistin use.
    Sarkar S; DeSantis ER; Kuper J
    Am J Health Syst Pharm; 2007 Dec; 64(23):2462-6. PubMed ID: 18029951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
    Huang J; Tang YQ; Sun JY
    Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring Colistin Resistance in Food Animals, An Urgent Threat.
    Liu Y; Liu JH
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):443-446. PubMed ID: 29865881
    [No Abstract]   [Full Text] [Related]  

  • 58. Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study.
    Markou N; Fousteri M; Markantonis SL; Zidianakis B; Hroni D; Boutzouka E; Baltopoulos G
    J Antimicrob Chemother; 2012 Oct; 67(10):2459-62. PubMed ID: 22790220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gelofusine Ameliorates Colistin-Induced Nephrotoxicity.
    Sivanesan SS; Azad MAK; Schneider EK; Ahmed MU; Huang J; Wang J; Li J; Nation RL; Velkov T
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016.
    Xavier BB; Lammens C; Ruhal R; Kumar-Singh S; Butaye P; Goossens H; Malhotra-Kumar S
    Euro Surveill; 2016 Jul; 21(27):. PubMed ID: 27416987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.